Translation of immunomodulatory therapy to treat chronic heart failure: Preclinical studies to first in human

BACKGROUND: Inflammation has been associated with progression and complications of chronic heart failure (HF) but no effective therapy has yet been identified to treat this dysregulated immunologic state. The selective cytopheretic device (SCD) provides extracorporeal autologous cell processing to l...

Descripción completa

Detalles Bibliográficos
Autores principales: Humes, H. David, Aaronson, Keith D., Buffington, Deborah A., Sabbah, Hani N., Westover, Angela J., Yessayan, Lenar T., Szamosfalvi, Balazs, Pagani, Francis D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079025/
https://www.ncbi.nlm.nih.gov/pubmed/37023139
http://dx.doi.org/10.1371/journal.pone.0273138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079025/
https://www.ncbi.nlm.nih.gov/pubmed/37023139
http://dx.doi.org/10.1371/journal.pone.0273138

Ejemplares similares